Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

350 Views

Poster Session: Antimicrobial Novel Agents

1675 - **Activity of Gepotidacin Against Escherichia coli Isolates from Community-acquired Urinary Tract Infections Collected Between 2019-2021 in the United States**

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

SA

SJ Ryan Arends, PhD

Principal Scientist
JMI Laboratories
North Liberty, Iowa, United States
DB

Deborah Butler, PharmD

VP & Head of Emerging Markets Regulatory Affairs at GSK
GSK
London, England, United Kingdom
NS

Nicole E. Scangarella-Oman, MS

Scientific Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
LT

Lindsey Tholen, BS (ASCP)

Microbiologist III
JMI Laboratories
North Liberty, Iowa, United States
JS

Jennifer M. Streit, BS, MT(ASCP)

Surveillance Manager
JMI Laboratories
North Liberty, Iowa, United States

Presenting Author(s)

RM

Rodrigo E. Mendes, PhD

Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States